Value Evaluation of Quantitative Aspergillus fumigatus-Specific IgG Antibody Test in the Diagnosis of Non-neutropenic Invasive Pulmonary Aspergillosis
Lingyan Sheng,Wenhong Jiang,Yake Yao,Jianying Zhou,Hua Zhou
DOI: https://doi.org/10.2147/idr.s460513
2024-05-24
Infection and Drug Resistance
Abstract:Lingyan Sheng, 1, &ast Wenhong Jiang, 1, 2, &ast Yake Yao, 1 Jianying Zhou, 1 Hua Zhou 1 1 Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, People's Republic of China; 2 Department of Respiratory and Critical Care Medicine, Jiangshan People Hospital, Quzhou, 324110, People's Republic of China &astThese authors contributed equally to this work Correspondence: Hua Zhou, Email Background: The role of Aspergillus -specific IgG antibody test in the diagnosis of non-neutropenic invasive pulmonary aspergillosis (IPA) is still uncertain, and related studies are also limited. Purpose: This study aims to evaluate the quantitative test value of Aspergillus fumigatus -specific IgG antibody in non-neutropenic IPA, which could provide additional evidence for related clinical diagnosis. Methods: This prospective study collected clinical data of suspected IPA patients from January, 2020 to December, 2022, and patients were divided into two groups, IPA and non-IPA. The study analyzed clinical characteristics and diagnostic value of Aspergillus -specific IgG antibody test, using the receiver operating characteristic (ROC) curve to evaluate diagnostic efficacy. Results: The study enrolled 59 IPA cases and 68 non-IPA cases, the average admission age of IPA group was 63.2± 9.6 (33– 79), and the gender ratio (male:female) of IPA group was 42:17. The proportion of patients with history of smoking and COPD were higher in IPA group (59.3% vs 39.7%, P =0.027; 33.9% vs 14.7%, P =0.011, respectively). The level of Aspergillus fumigatus -specific IgG antibody in IPA group was significantly higher than non-IPA group (202.1± 167.0 vs 62.6± 58.0, P < 0.001). The area under the ROC curve was 0.799 (95%CI: 0.718, 0.865 P < 0.001), and the cut-off with best diagnostic efficacy was 91 AU/mL. Conclusion: Immunological test plays an important role in the diagnosis of pulmonary aspergillosis, and Aspergillus -specific IgG antibody test has the good diagnostic value in non-neutropenic IPA. Keywords: Aspergillus , invasive pulmonary aspergillosis, IgG, non-neutropenic, diagnosis Aspergillus is one of the pathogenic fungi which may lead to life-threatening invasive infections. Approximately 50 species of Aspergillus are pathogenic to humans, most commonly Aspergillus fumigatus , which accounts for more than 90% of Aspergillus infections. 1,2 Therefore, it is essential to deal with different issues of A. fumigatus on clinical work. Aspergillosis is defined as different kinds of diseases caused by Aspergillus , and pulmonary aspergillosis (PA) is the main clinical manifestation. 3 The spectrum of PA is wide, including IPA, various kinds of chronic pulmonary aspergillosis (CPA) and allergic bronchopulmonary aspergillosis (ABPA), and IPA is the most severe pattern, which is more common in severely immunosuppressed patients. 4 People's innate immune system plays an important role in immune response against Aspergillus , specifically, IL-1β and tumor necrosis factor (TNF) engage immune and nonimmune cells, balance of Th1 and Th2 cytokines modulates the intensity of the response, and anti-inflammatory cytokines suppress inflammation during recovery. 5 In recent years, the morbidity and mortality of PA have gradually increased, and the increase of IPA cases is one of the main reasons for this phenomenon, especially those non-neutropenic cases. Global data in 2017 indicated that there were approximately 250,000 new IPA cases each year. Previous studies have shown that the incidence of IPA was 15%, and the mortality rate could be as high as 30~80% in patients with immune deficiency. 6,7 Therefore, early diagnosis and timely treatment are essential to reduce mortality and improve prognosis of IPA. At present, IPA diagnosis should consider clinical features, radiology, histopathology, immunology – mainly refers to specific antigen tests, including galactomannan (GM) test, 1, 3-β-D-glucan (BDG) test (G test) – and microbiology all together, and exclude alternative diagnosis. 6 Among the above diagnostic methods, immunological tests have advantages of convenient operation, high sensitivity and specificity, short-time duration and less trauma. 6,8 Previous studies have proved that GM test in serum and bronchial alveolar lavage fluid (BALF) have higher sensitivity and specificity for diagnosis of IPA than CPA. 9 G test has -Abstract Truncated-
pharmacology & pharmacy,infectious diseases